1.Complex Coil Assisted Single Coil Embolization for Small Intracranial Aneurysm.
Ming Shiang YANG ; Tzu Hsien YANG ; Chang Hsien OU ; Si Wa CHAN ; Tai I CHEN ; Chia Jung YANG ; Chia Ming CHIANG ; Wen Chien HUANG
Neurointervention 2013;8(2):105-109
The purpose of the technical note is to introduce the complex coil assisted coil embolization method in the treatment of intracranial small aneurysm, in order to enhance the safety of the procedure. The first microcatheter was navigated into the aneurysm sac and the ultrasoft coil was used as the embolization coil. If the embolizations coil could not stay within the aneurysm sac smoothly, such as coil herniation into parent artery during the delivery process. The second microcatheter would be navigated to the aneurysm level in the parent artery. Another complex coil was delivered within the parent artery via the second microcatheter to provide the neck bridge effect in order to enhance the stability of embolization coil. Besides, the protection coil will not disturb the parent artery flow. While the embolization coil was put into the aneurysm sac smoothly under the help of complex protective coil, the protective coil was then withdrawn gently. We use the most magnified view, dual-plane approach simultaneously to observe the stability of embolization coil. The embolization coil would be detached without any evidence of coil motion or vibration. The new method could provide the physiological protective method, without leaving any protective device such as stent within the parent artery.
Aneurysm
;
Arteries
;
Humans
;
Intracranial Aneurysm
;
Neck
;
Parents
;
Protective Devices
;
Stents
;
Vibration
2.An update of preimplantation genetic diagnosis in gene diseases, chromosomal translocation, and aneuploidy screening.
Li Jung CHANG ; Shee Uan CHEN ; Yi Yi TSAI ; Chia Cheng HUNG ; Mei Ya FANG ; Yi Ning SU ; Yu Shih YANG
Clinical and Experimental Reproductive Medicine 2011;38(3):126-134
Preimplantation genetic diagnosis (PGD) is gradually widely used in prevention of gene diseases and chromosomal abnormalities. Much improvement has been achieved in biopsy technique and molecular diagnosis. Blastocyst biopsy can increase diagnostic accuracy and reduce allele dropout. It is cost-effective and currently plays an important role. Whole genome amplification permits subsequent individual detection of multiple gene loci and screening all 23 pairs of chromosomes. For PGD of chromosomal translocation, fluorescence in-situ hybridization (FISH) is traditionally used, but with technical difficulty. Array comparative genomic hybridization (CGH) can detect translocation and 23 pairs of chromosomes that may replace FISH. Single nucleotide polymorphisms array with haplotyping can further distinguish between normal chromosomes and balanced translocation. PGD may shorten time to conceive and reduce miscarriage for patients with chromosomal translocation. PGD has a potential value for mitochondrial diseases. Preimplantation genetic haplotyping has been applied for unknown mutation sites of single gene disease. Preimplantation genetic screening (PGS) using limited FISH probes in the cleavage-stage embryo did not increase live birth rates for patients with advanced maternal age, unexplained recurrent abortions, and repeated implantation failure. Polar body and blastocyst biopsy may circumvent the problem of mosaicism. PGS using blastocyst biopsy and array CGH is encouraging and merit further studies. Cryopreservation of biopsied blastocysts instead of fresh transfer permits sufficient time for transportation and genetic analysis. Cryopreservation of embryos may avoid ovarian hyperstimulation syndrome and possible suboptimal endometrium.
Abortion, Habitual
;
Abortion, Spontaneous
;
Alleles
;
Aneuploidy
;
Biopsy
;
Blastocyst
;
Chimera
;
Chromosome Aberrations
;
Comparative Genomic Hybridization
;
Cryopreservation
;
Embryonic Structures
;
Endometrium
;
Female
;
Fluorescence
;
Genetic Testing
;
Genome
;
Humans
;
Live Birth
;
Mass Screening
;
Maternal Age
;
Mitochondrial Diseases
;
Mosaicism
;
Ovarian Hyperstimulation Syndrome
;
Patient Dropouts
;
Polar Bodies
;
Polymorphism, Single Nucleotide
;
Pregnancy
;
Preimplantation Diagnosis
;
Prostaglandins D
;
Translocation, Genetic
;
Transportation
;
Vitrification
3.Association Between Exposure to Particulate Matter and the Incidence of Parkinson’s Disease: A Nationwide Cohort Study in Taiwan
Ting-Bin CHEN ; Chih-Sung LIANG ; Ching-Mao CHANG ; Cheng-Chia YANG ; Hwa-Lung YU ; Yuh-Shen WU ; Winn-Jung HUANG ; I-Ju TSAI ; Yuan-Horng YAN ; Cheng-Yu WEI ; Chun-Pai YANG
Journal of Movement Disorders 2024;17(3):313-321
Objective:
Emerging evidence suggests that air pollution exposure may increase the risk of Parkinson’s disease (PD). We aimed to investigate the association between exposure to fine particulate matter (PM2.5) and the risk of incident PD nationwide.
Methods:
We utilized data from the Taiwan National Health Insurance Research Database, which is spatiotemporally linked with air quality data from the Taiwan Environmental Protection Administration website. The study population consisted of participants who were followed from the index date (January 1, 2005) until the occurrence of PD or the end of the study period (December 31, 2017). Participants who were diagnosed with PD before the index date were excluded. To evaluate the association between exposure to PM2.5 and incident PD risk, we employed Cox regression to estimate the hazard ratio and 95% confidence interval (CI).
Results:
A total of 454,583 participants were included, with a mean (standard deviation) age of 63.1 (9.9) years and a male proportion of 50%. Over a mean follow-up period of 11.1 (3.6) years, 4% of the participants (n = 18,862) developed PD. We observed a significant positive association between PM2.5 exposure and the risk of PD, with a hazard ratio of 1.22 (95% CI, 1.20–1.23) per interquartile range increase in exposure (10.17 μg/m3) when adjusting for both SO2 and NO2.
Conclusion
We provide further evidence of an association between PM2.5 exposure and the risk of PD. These findings underscore the urgent need for public health policies aimed at reducing ambient air pollution and its potential impact on PD.